211 related articles for article (PubMed ID: 32572713)
1. Hormone replacement therapy and mammographic density: a systematic literature review.
Azam S; Jacobsen KK; Aro AR; Lynge E; Andersen ZJ
Breast Cancer Res Treat; 2020 Aug; 182(3):555-579. PubMed ID: 32572713
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
3. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
7. Menopause, hormone replacement therapy and cancer.
La Vecchia C; Brinton LA; McTiernan A
Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
Kim S; Ko Y; Lee HJ; Lim JE
Breast Cancer Res Treat; 2018 Aug; 170(3):667-675. PubMed ID: 29713854
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users.
Ellingjord-Dale M; Lee E; Couto E; Ozhand A; Qureshi S; Hofvind S; Van Den Berg DJ; Akslen LA; Grotmol T; Ursin G
Breast Cancer Res; 2012 Oct; 14(5):R135. PubMed ID: 23095343
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and breast cancer: revisiting the issues.
DeGregorio MW; Taras TL
J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
[TBL] [Abstract][Full Text] [Related]
12. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
13. [THE EFFECTS OF HORMONAL REPLACEMENT THERAPY (HRT) ON MAMMOGRAPHIC BREAST DENSITY AND ABNORMAL MAMMOGRAMS PROMPTING FURTHER INVESTIGATION].
Barda L; Nevler A; Rosin D; Shabtai EL; Gutman M; Shabtai M
Harefuah; 2019 Apr; 158(4):239-243. PubMed ID: 31032556
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
15. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy regimens and breast cancer risk(1).
Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
Jernström H; Bendahl PO; Lidfeldt J; Nerbrand C; Agardh CD; Samsioe G
Cancer Causes Control; 2003 Sep; 14(7):673-80. PubMed ID: 14575365
[TBL] [Abstract][Full Text] [Related]
18. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149
[TBL] [Abstract][Full Text] [Related]
19. Association of Catechol-O-methyltransferase polymorphism Val158Met and mammographic density: A meta-analysis.
Kallionpää RA; Uusitalo E; Peltonen J
Gene; 2017 Aug; 624():34-42. PubMed ID: 28473194
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]